CompletedPhase 1psilocybin

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

Sponsored by Joshua Woolley

NCT ID
NCT02950467
Target Enrollment
30 participants
Start Date
2018-01-05
Est. Completion
2019-12-31

About This Study

The purpose of this study is to determine whether psilocybin-assisted group psychotherapy is a safe and feasible treatment for demoralization in long-term AIDS survivors (LTAS).

Conditions Studied

DistressDepressionGrief

Interventions

  • Psilocybin
  • Modified brief Supportive Expressive Group Therapy

Eligibility

Age:50 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criterion:

* Older individuals who are long-term AIDS survivors and suffer from moderate-to-severe demoralization.

Exclusion Criteria:

* A physical, neurological or cognitive condition that makes participating in the study unsafe or unfeasible.
* Regular psychotropic medication use.
* Personal or family history of serious mental illness.
* Severe depression requiring immediate standard-of-care treatment.
* Exclusion by the clinical judgment of the study investigators.

Study Locations (1)

University of California, San Francisco
San Francisco, California, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source